+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID06778174

Observational Study on the Treatment and Outcomes of Progressive Familial Intrahepatic Cholestasis with Genetic Confirmation

Led by University Medical Center Groningen · Updated on 2025-01-24

200

Participants Needed

1

Research Sites

304 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a prospective observational study to better understand Progressive Familial Intrahepatic Cholestasis PFIC, a group of very rare genetic liver diseases. The study aims to track the natural course and prognosis of various PFIC types, evaluate the effects of different treatments including symptomatic therapies, surgical or medical interruption of enterohepatic circulation, and newer therapies like correctorpotentiator or exon skipping. It also seeks to identify complications from these treatments, understand biochemical changes over time, and explore genotype-phenotype relationships where possible. This study observes patients with genetically confirmed PFIC types such as FIC1 deficiency PFIC1, BSEP deficiency PFIC2, MDR3 deficiency PFIC3, and other rarer genetic subtypes. The study does not assign any specific treatment, focusing instead on collecting real-world data about patients treatments and disease progression over time. Follow-up includes monitoring biochemical, clinical, and surgical parameters, including liver transplantation status. Participants are followed longitudinally for as long as possible, with data collected on liver transplantation occurrence at various ages and mortality rates. Biochemical markers and clinical outcomes are recorded to associate changes with treatments and disease course. The study intends to provide broad insights into PFICs progression, treatment safety, and outcomes, supporting future predictions and personalized care strategies.

CONDITIONS

Brief Title

Prospective Analysis of the Treatment of Progressive Familial Intrahepatic Cholestasis (TreatFIC)

Research Team

H

Henkjan J Verkade, MD, PhD, Professor

W

Willem S Lexmond, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here